CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...